The Old Way: When researchers want to test a potential cancer drug on a brain tumor, they surgically remove the tumor and run tests in a laboratory setting.
The problem is that tumors don’t behave the same way once removed from the brain. So, the laboratory tests have not produced any major steps forward for curing cancers.
Patients still have to go through toxic chemotherapy and harmful radiation treatments that have major, long-lasting side effects. And, many patients die from their “treatment” itself!
Plus, each research institution keeps their results to themselves for the sake of maximising profits. This slows down innovation, costs the company more money, and costs patients their lives.
Fortunately, there’s a better way.
The NeuVisium Way: We are building the Glioma Discovery Commons, a collaborative group of medical institutions that
